Effects of Na-sucrose octasulfate on skin and mucosa reactions during radiotherapy of head and neck cancers--a randomized prospective study
- PMID: 11765071
- DOI: 10.1080/02841860152619188
Effects of Na-sucrose octasulfate on skin and mucosa reactions during radiotherapy of head and neck cancers--a randomized prospective study
Abstract
Na sucrose octasulfate (Na SOS) was tested for ability to relieve radiation-induced acute skin and mucosal reactions in patients with head and neck cancer. Sixty patients were included in this prospective, double-blind, randomized study. Skin and mucosal reactions were scored using several variables. No statistically significant difference was found between the results with Na SOS and those with placebo for any of the variables, with the exception of skin desquamation, which showed a significant difference in the placebo group. The most likely explanation for this is that the Na SOS gel itself left behind a flaky layer that was difficult to distinguish from radiation-induced flaking. In conclusion, we cannot recommend Na SOS in the routine management of radiation-induced skin and mucosal reactions.
Similar articles
-
Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study.Acta Oncol. 1995;34(2):219-23. doi: 10.3109/02841869509093959. Acta Oncol. 1995. PMID: 7718260 Clinical Trial.
-
The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):643-50. doi: 10.1016/j.ijrobp.2006.09.043. Int J Radiat Oncol Biol Phys. 2007. PMID: 17293228 Clinical Trial.
-
Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.Australas Radiol. 2006 Oct;50(5):468-74. doi: 10.1111/j.1440-1673.2006.01628.x. Australas Radiol. 2006. PMID: 16981945 Clinical Trial.
-
[Management of mucositis following radiotherapy for head and neck cancers].Cancer Radiother. 2001 Nov;5 Suppl 1:121s-130s. Cancer Radiother. 2001. PMID: 11797271 Review. French.
-
Glutamine in Alleviation of Radiation-Induced Severe Oral Mucositis: A Meta-Analysis.Nutr Cancer. 2016 Jul;68(5):734-42. doi: 10.1080/01635581.2016.1159700. Epub 2016 Apr 4. Nutr Cancer. 2016. PMID: 27045857 Review.
Cited by
-
Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature.Curr Oncol. 2010 Aug;17(4):94-112. doi: 10.3747/co.v17i4.493. Curr Oncol. 2010. PMID: 20697521 Free PMC article.
-
Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group.Support Care Cancer. 2013 Oct;21(10):2933-48. doi: 10.1007/s00520-013-1896-2. Epub 2013 Aug 14. Support Care Cancer. 2013. PMID: 23942595 Review.
-
Topical interventions to prevent acute radiation dermatitis in head and neck cancer patients: a systematic review.Support Care Cancer. 2017 Mar;25(3):1001-1011. doi: 10.1007/s00520-016-3521-7. Epub 2016 Dec 12. Support Care Cancer. 2017. PMID: 27957620
-
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients.Support Care Cancer. 2013 Nov;21(11):3191-207. doi: 10.1007/s00520-013-1871-y. Epub 2013 Jul 6. Support Care Cancer. 2013. PMID: 23832272
-
The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline.Support Care Cancer. 2006 Aug;14(8):802-17. doi: 10.1007/s00520-006-0063-4. Epub 2006 Jun 7. Support Care Cancer. 2006. PMID: 16758176
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical